Hanall Biopharma, Active Community... Stock Price -4.71%.
At this time, posts about HanAll Biopharma are rapidly increasing on portals and securities communities. Today, foreigners have net sold 142,000 shares of HanAll Biopharma, and institutions have net sold 2,000 shares, according to provisional data. HanAll Biopharma is known as an R&D-focused pharmaceutical bio company.
As of 11:31 AM on the 17th, HanAll Biopharma's stock price is 32,400 KRW, down 4.71% from the previous day, with a trading volume of 2,734,281 shares, which is 120.88% of the 5-day average trading volume.
In addition to HanAll Biopharma, posts by investors are also rapidly increasing for GemVax Link (064800), JW Pharmaceutical Preferred (001065), and Dongbang Seonki (099410).
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Nana Home Intruder Who Filed 'Counter Attempted Murder Complaint' Referred to Prosecution for False Accusation
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
